Skip to content
OpenCapital
Get started

Amphastar Pharmaceuticals AMPH EV / sales

EV / sales at other companies

Pfizer logo
PfizerPFE
3.5×+0.3×
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
6.3×-2.2×
Viatris logo
ViatrisVTRS
1.9×+0.3×
Opko Health logo
Opko HealthOPK
1.6×-0.1×
AptarGroup logo
AptarGroupATR
2.4×-0.6×
ARS Pharmaceuticals, Inc. logo
ARS Pharmaceuticals, Inc.SPRY
8.8×-3.5×

Other financials

Income statement

See full
Revenue$171.2M+0.4%
Gross profit$70.3M-17.5%
Operating income$13.6M-63.5%
Net income$6.4M-74.6%
EPS (diluted)$0.14-72.5%

Balance sheet

See full
Cash & equivalents$170.9M-6.5%
Total debt$686.6M+5.2%
Total equity$445.5M—
Total assets$1.6B+1.3%

Cash flow

See full
Operating cash flow$47.8M+36.4%
CapEx$9.5M-11.1%
Free cash flow$38.3M+57.2%

Valuation

See full
Market cap$926.83M-19.9%
Enterprise value$1.44B-11.4%
P/E11.7×+3.5×
P/S1.3×-0.3×

Profitability

See full
Gross margin47.3%-3.2pp
Operating margin16.2%-10.4pp
Net margin11%-8.4pp
FCF margin18.8%-1.8pp

Returns & leverage

See full
Return on equity14.7%—
Debt / equity0.2×—
Current ratio3.9×+0.9×

Where this comes from

Calculated from Amphastar Pharmaceuticals’s reported figures.

enterprise value/total revenue=1.9×

Based on the most recent quarter.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amphastar Pharmaceuticals's EV / sales?
Amphastar Pharmaceuticals (AMPH) reported EV / sales of 1.9× in Q1 2026.
How has Amphastar Pharmaceuticals's EV / sales changed year-over-year?
Amphastar Pharmaceuticals's EV / sales decreased by 23.1% year-over-year, from 2.5× to 1.9×.
What is the long-term trend for Amphastar Pharmaceuticals's EV / sales?
Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's EV / sales has grown at a -2.3% compound annual growth rate (CAGR), from 2.7× to 2.4×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.